Pfizer said it would stop studying the pill after a participant in one of its trials experienced a drug-induced liver injury.

YouTuber Pani Bottle has revealed the side effects of obesity treatment Wegovy. On the 14th, Pani Bottle wrote on his account ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Key Takeaways Pfizer said it will discontinue development of oral daily weight-loss treatment danuglipron.A Phase 3 trial participant experienced a "liver injury" while taking the drug that "resolved" ...

Pfizer will stop developing an obesity pill that has been closely watched by investors, a severe blow in its efforts to ...

A diverse range of medical specialists offer unique expertise for obesity treatment. “Endocrinologists, bariatricians, ...

However, sell-offs present great opportunities to buy stocks with significant upside potential. Further, CRISPR Therapeutics ...

Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...